Dr. Lu Hongtu
卢洪涂
Chief Physician; Professor; Doctoral Supervisor; Director of Pathology Department
Where they practice, who they consult.
- West China Hospital, Sichuan University, Chengdu
- 25+ years in surgical and neuropathology
- English, Mandarin
What they personally lead.
Training and recognition
West China Hospital pathology serves as a regional reference lab for southwestern China with consult volume above 60,000 cases annually; runs molecular workups for the integrated WHO 2021 CNS tumor classification including IDH1/2, 1p/19q codeletion, MGMT, H3 K27, and TERT promoter testing; co-author of Chinese neuropathology consensus documents
What to expect
Useful for glioma patients who need integrated histologic + molecular diagnosis under WHO 2021 criteria, especially when local labs do not offer the full panel. <!-- TODO: needs second source -->
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Lu Hongtu's background to other specialists in Chengdu. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.